Related Experiment Video
Updated: Jul 3, 2025

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
Published on: April 28, 2022
Aging-Related Protein Alterations in the Brain
Rafay Ali Syed1,2, Mahnoor Hayat1,3, Hammad Qaiser1
1Department of Biological Sciences, Faculty of Basic & Applied Sciences, International Islamic University Islamabad, Pakistan.
Aging and Alzheimer's disease (AD) alter brain proteins like amyloid and tau. Understanding these molecular changes is key to developing new diagnostic and therapeutic strategies for AD.
Area of Science:
- Neuroscience
- Molecular Biology
- Gerontology
Background:
- Aging is a natural process leading to physiological decline and increased disease risk.
- Alzheimer's disease (AD), a common age-associated neurological disorder, involves complex molecular changes in the brain.
- Key proteins affected include amyloid, tau, metalloproteins, and neurotrophic factors.
Purpose of the Study:
- To review the impact of aging and AD on brain molecular pathways and protein levels.
- To discuss the roles of specific proteins such as amyloid-beta, tau, and neurotrophic factors in AD pathogenesis.
- To highlight the need for further research into metal ion transport mechanisms in AD.
Main Methods:
- Literature review focusing on molecular mechanisms in aging and Alzheimer's disease.
- Analysis of protein alterations, including metalloproteins, neurotrophic factors, amyloid, and tau.
- Examination of the influence of aging and AD on protein processing and cellular pathways.
Main Results:
- Aging and AD significantly affect the levels and processing of amyloid precursor protein (AβPP) and amyloid-beta (Aβ).
- Tau protein, crucial for neuronal function, is altered in AD.
- Changes in neurotrophic factors like nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) are observed, with potential protective roles.
Conclusions:
- Understanding the molecular interplay of proteins during aging and AD is crucial.
- Further research into metal ion (e.g., Cu2+) transport by Aβ and AβPP is warranted.
- Elucidating these molecular pathways may lead to novel diagnostic and therapeutic interventions for AD.
More Related Videos
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
11:57Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans
Published on: November 26, 2017
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Neural Regulation
Alzheimer's Disease: Treatment